[
    "{\"step_by_step_thinking\": \"The question is asking about the group of people in which the Pneumococcal vaccine PCV 23 polysaccharide has shown the best results. From the documents, it is clear that the PCV 23 vaccine is not recommended for children under 2 years of age (Document 6). There is no specific mention of the vaccine's effectiveness in people with sickle cell anemia, cystic fibrosis, or recurrent otitis media and sinusitis. Therefore, none of the options seem to be supported by the provided documents.\", \"answer_choice\": \"None of the above\"}"
]